NCT02998502View on ClinicalTrials.gov

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 5, 2019

Study Completion Date

February 1, 2021

Conditions
AnxietyPanic Disorder
Interventions
DEVICE

Freespira Breathing System

Over an 8-week period the efficacy of the FBS system in youth will be tested, with those in the randomized active device group. The control group will not receive the device until completion of the 8 week baseline.

Trial Locations (1)

21218

Johns Hopkins University, Baltimore

Sponsors
All Listed Sponsors
collaborator

Palo Alto Health Sciences, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT02998502 - The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens | Biotech Hunter | Biotech Hunter